Beijing in talks for license rights on Pfizer's Paxlovid

If successful, that would allow domestic Chinese pharmaceutical companies to manufacture and distribute a generic version of the drug, Reuters reported citing three sources.

Beijing's aim was to have a deal in place before the Lunar New Year on 22 January, one source reportedly said.

-- More to follow --